The benefit of reduced serum phosphate levels depends on patient characteristics: a nationwide cohort study
The benefit of intensive phosphate management may be pronounced in patients with a history of ACVD or DN. A comprehensive approach that considers both age and nutritional status may be necessary when managing serum phosphate levels.
Authors
- Masanori Abe (ORCID: https://orcid.org/0000-0002-9156-5415)
- Takayuki Hamano (ORCID: https://orcid.org/0000-0002-2100-9106)
- Kosaku Nitta (ORCID: https://orcid.org/0000-0002-9548-054X)
- Masatomo Taniguchi (ORCID: https://orcid.org/0009-0009-2862-3457)
- Hideki Fujii (ORCID: https://orcid.org/0000-0001-7610-1068)
- Shunsuke Goto (ORCID: https://orcid.org/0000-0002-7102-2843)
- Shinichi Nishi (ORCID: https://orcid.org/0000-0002-8495-9168)
Institutions
- Nihon University (JP)
- Nagoya City University (JP)
- Japanese Society for Dialysis Therapy (JP)
- Tokyo Women's Medical University (JP)
- Saiseikai Fukuoka General Hospital (JP)
- Kobe University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/ckj/sfae263
- Citations
- 4
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- Kissei
- Kyowa Kirin Pharmaceutical Development
- Torii Pharmaceutical
- Astellas Pharma
- Chugai Pharmaceutical